M&A in a COVID climate

M&A in a COVID climate

M&A in a COVID climate

M&A in a COVID climate COVID-19 has had and will continue to have a significant impact on M&A transactions in the UK. UK M&A deal activity is materially down on 2019. Whilst there is a school of thought that being an event-led and sector agnostic crisis markets will experience a swift rebound, there is by no means a consensus.

What seems universal however, is the belief that when sentiment recovers and activity levels return the M&A process will have changed significantly.

This briefing considers some of the key areas of the private M&A transaction process likely to be affected by the on-going effects of the pandemic.

Johnathan Rees Partner | Head of Corporate & Commercial johnathan.rees@laytons.com +44 (0)20 7842 8009

2

M&A in a COVID climate

Wary buyers Whilst there is unquestionably a lot of cash in the system particularly amongst private equity buyers - not to mention considerable pent-up demand as deals previously paused are revived and distressed M&A appears on the horizon, as and when the market recovers it is likely to look very different from the one that existed pre-COVID. Irrespective of supply and demand, the likelihood is that buyers will be proceeding carefully meaning a selective approach, longer transaction timelines, granular due diligence and carefully negotiated acquisition agreements.

operates), examples of potential areas of concern for buyers include: • exposure to supply chain disruption • material contracts (including termination rights and force majeure provisions).

• target’s compliance with applicable COVID-19 emergency laws and regulations.

• cybersecurity and data protection risks arising from remote working • business continuity planning, and how effectively the target has adapted its business to operate during the COVID-19 crisis and its aftermath • insurance cover for losses arising from a business

Transaction structures Risk sharing and mitigation will be front and centre for most buyers. This in turn is likely to see an upturn in carve-outs, share for share exchanges as well as partial exits coupled with put and call options. Conversely sellers will want certainty and be keen to ensure that they don’t leak value as a result of the market’s volatility.

slowdown or stoppage • a range of employment related issues including details of: • furloughing of the target’s employees under the Job Retention Scheme or other COVID-related changes to employment or cost-cutting measures introduced by the target • compliance with employment and health and safety laws as part of its COVID response plan and steps taken to discharge the target’s duty to

Due diligence Due diligence will have increased importance for buyers who in addition to the usual investigations will want to evaluate the impact that the pandemic has had or may have on the target and its ability to handle similar situations in the future e.g. a further wave of the pandemic and national or regional lockdowns.

While the specific areas that may require enhanced COVID-19 related due diligence will vary according to the circumstances of the transaction (including factors such as the transaction structure - share purchase or asset purchase - and the particular industry or sector in which the target

3

protect the health and safety of its workforce • details of the target’s participation in any government support schemes, repayment arrangements and the impact of any change of control of the target The logistical aspects of the due diligence process will also need to be reconsidered. While the use of virtual data rooms is an established tool of M&A transactions, sellers may experience difficulties in collating the information required to populate the data room e.g. where personnel or advisors are unable to gain physical access to the relevant documentation at the target’s locations.

M&A in a COVID climate

Valuation issues The current environment presents unique challenges for buyers when valuing businesses. The impact of the pandemic and its aftermath on the target’s underlying commercial operations, its supply chains, route to market and customer demand will undermine the accuracy and reliability of the buyer’s data. The lack of comfort in forecast future earnings and reliability of projections will inevitably impact confidence and valuations.

Where the target has experienced a significant economic downturn as a result of the current crisis, it is likely that buyer and seller will have very different views regarding the target’s recovery – both speed and extent - once the trading conditions stabilize.

These factors will in turn influence pricing, payment and contractual negotiations.

Earn-outs - where part of the purchase price is conditional upon the future financial performance of the target – are a useful tool to bridge the gap between the principals' valuations. From a buyer's perspective the structure mitigates risk of over-paying, eases cash-flow and limits exposure in the earn-out period. From a seller's perspective an earn-out presents an opportunity for it to achieve full value and can be a reasonable compromise provided the earn-out payment reflects the risk inherent in these arrangements.

All that being said, earn-outs can be notoriously complex and represent neither a clean break nor certainty – key objectives for sellers.

There are a number of key issues for the parties from agreeing the financial metrics, monitoring performance and the length of the earn-out period to the element of control which the seller will have over the target business in the earn-out period.

Price and payment Given the continuing uncertainty created by the pandemic and the question of the reliability of due diligence exercises, buyers will be keen to adopt pricing and payment structures which help to mitigate their risk. The “4 R’s” will set most agendas – the buyer’s desire to mitigate risk and ensure recovery of over-payment through purchase price adjustments and the seller’s desires to receive and retain the purchase price.

This may mean a revival of contingent (e.g. earn-outs) and deferred payment arrangements as well a variety of postclosing price adjustment mechanisms. The seller-friendly locked-box arrangements may be placed back in their own box for a period.

Negotiations • If the purchase price is subject to post completion adjustment or contingent on future performance, the share purchase agreement will include a number of detailed provisions which can often be complex and time consuming to settle. These will include: • completion accounts involving a post-closing “true-up” of some aspect of the target’s balance sheet • earn-out mechanics including conduct of business “ring-fencing” protections for the seller • retention or escrow arrangements • deferred payment terms and security arrangements • conduct of business provisions during any period between signing and completion 4

M&A in a COVID climate

• Buyers will scrutinise their warranty and indemnity

Deal process and timetable

protection and seek to address specific COVID-related risks (e.g. compliance with new legislation introduced

It is perhaps inevitable that parties can anticipate extended

to manage the COVID-19 outbreak and the efficacy

transaction timescales as the logistical challenges and

of the target’s business continuity, crisis management

government restrictions have the potential to extend various

and disaster recovery plans).

phases of the transaction process from due diligence to tax clearances and regulatory approvals.

• Where there is a split between signing and completion (e.g. a 3rd party consent or approval is required) the

Parties should factor these elements into timetables to

buyer will look to negotiate a full material adverse

ensure that they are realistic. Similarly any notice periods

change provision giving it the flexibility to withdraw

and longstop dates in the transaction documentation should

from the transaction if there is a significant downturn

reflect these issues.

in the target’s fortunes during that period.

• Indeed it is plausible that buyers will look to introduce conditionality to protect against specific risks which

Government intervention

could materially affect the value of the target’s business. These might include comfort letters from key

The UK’s current regulatory intervention regime is

suppliers and customers, as well as a range of COVID-

contained in the Enterprise Act 2002 which at present allows

related conditions e.g. no second or further wave

intervention if one or more public interest considerations

of the outbreak having occurred, the introduction

are present – broadly divided into national security, media

of COVID-related legislative measures that render

plurality and stability of the UK financial system.

the target’s business economically unviable or the re-opening or continued operation of the target’s key sites.

In the current climate these risk allocation measures will be more important – and more finely negotiated - than ever.

Following an inquiry launched earlier in the year the UK government recently added a new public intervention ground enabling it to intervene in M&A transactions in order to deal with public health emergencies.

The government has stated that these changes are

All this points to transaction documentation becoming

intended to mitigate risks in the short term and that

increasingly heavily negotiated with all that entails for the

more comprehensive powers to scrutinise and intervene

parties, their costs and their businesses.

in takeovers and mergers to protect national security will be introduced in the forthcoming National Security and Investment Bill.

Given these factors it is possible that UK M&A transactions will experience increased scrutiny and government intervention.

5

M&A in a COVID climate

That said, with Brexit – in some form or another – fast approaching and the UK government’s unambiguous aim to encourage overseas investment and throw “our doors open” to global business, the sensitivity of intervention in this arena is obvious.

Watch this space.

In Conclusion While there are good reasons to anticipate a recovery in UK M&A activity, the pandemic has ensured that transactions in the new order will look, in the near term at least, very different from the world pre-COVID-19.

Please contact Johnathan Rees if you would like to discuss any of the issues raised in this article.

6

M&A in a COVID climate

Expertise

Corporate & Commercial We provide a complete range of corporate and commercial advice and support for clients who extend from start-ups, individual entrepreneurs and family offices to multinational corporations.

Our teams focus on acquiring a deep understanding of the particular needs and objectives of our clients to deliver advice and outcomes that are tailored to those needs and objectives and which meet them swiftly and cost-effectively. The approach to technical problems is informed, insightful and proportionate, and we take pride in viewing problems from a fresh perspective to provide innovative solutions.

7

John Gavan

Esther Gunaratnam

Paddy Kelly

Partner john.gavan@laytons.com +44 (0)20 7842 8000

Partner esther.gunaratnam@laytons.com +44 (0)20 7842 8000

Partner paddy.kelly@laytons.com +44 (0)20 7842 8018

Robert MacGinn

Brian Miller

Daniel Oldfield

Partner robert.macginn@laytons.com +44 (0)20 7842 8000

Partner brian.miller@laytons.com +44 (0)20 7842 8000

Partner daniel.oldfield@laytons.com +44 (0)20 7842 8037

Daniele Penna

Johnathan Rees

Christopher Sherliker

Partner daniele.penna@laytons.com +44 (0)20 7842 8053

Partner johnathan.rees@laytons.com +44 (0)20 7842 8009

Partner christopher.sherliker@laytons.com +44 (0)20 7842 8015

Cameron Sunter

Liza Zucconi

Partner cameron.sunter@laytons.com +44 (0)20 7842 8036

Partner liza.zucconi@laytons.com +44 (0)20 7842 8092

2 More London Riverside, London SE1 2AP +44 (0)20 7842 8000 | london@laytons.com laytons.com

Š Laytons LLP which is authorised and regulated by the Solicitors Regulation Authority (SRA Nº 566807). A list of members is available for inspection at the above offices.